Retrospective study of the safety of caspofungin in immunocompromised pediatric patientsFRANKLIN, Jeremy A; MCCORMICK, John; FLYNN, Patricia M et al.The Pediatric infectious disease journal. 2003, Vol 22, Num 8, pp 747-749, issn 0891-3668, 3 p.Article

Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin TreatmentDESNOS-OLLIVIER, Marie; MOQUET, Olivier; CHOUAKI, Taieb et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 6, pp 2304-2306, issn 0095-1137, 3 p.Article

The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to AspergillusAYCICEK, Abdullah; CETINKAYA, Zafer; KIYICI, Halil et al.European archives of oto-rhino-laryngology. 2009, Vol 266, Num 11, pp 1703-1709, issn 0937-4477, 7 p.Article

Nouveaux antifongiques systémiques = New antifungalsCAZENAVE, B; LANTERNIER, F; LORTHOLARY, O et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 5, pp 178-184, issn 0296-9009, 7 p.Article

Efficacy and safety of caspofungin therapy in children with invasive fungal infectionsMERLIN, Etienne; GALAMBRUN, Claire; RIBAUD, Patricia et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 12, pp 1186-1188, issn 0891-3668, 3 p.Article

Caspofungin : an advanced treatment approach for suspected or confirmed invasive aspergillosisMAERTENS, Johan.International journal of antimicrobial agents. 2006, Vol 27, Num 6, pp 457-467, issn 0924-8579, 11 p.Article

Pharmacokinetic characteristics of caspofungin in Two pediatric liver transplant patientsNEELY, Michael; BLUMER, Jeffrey.Current therapeutic research. 2003, Vol 64, Num 2, pp 127-136, issn 0011-393X, 10 p.Article

Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use studyKARTSONIS, Nicholas A; SAAH, Alfred; LIPKA, C. Joy et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 878-881, issn 0305-7453, 4 p.Article

Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective ConcentrationFULLER, Jeff; SCHOFIELD, Adam; JIWA, Safeer et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 2, pp 479-482, issn 0095-1137, 4 p.Article

Assessment of the paradoxical effect of caspofungin in therapy of candidiasisCLEMENS, Karl V; ESPIRITU, Marife; PARMAR, Rachana et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1293-1297, issn 0066-4804, 5 p.Article

Caspofungin Affects Growth of Paracoccidioides brasiliensis in Both Morphological PhasesRODRIGUEZ-BRITO, Sabrina; NINO-VEGA, Gustavo; SAN-BLAS, Gioconda et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5391-5394, issn 0066-4804, 4 p.Article

Breakthrough invasive mould infections in patients treated with caspofunginPHAI PANG, Katy-Anna; GODET, Cendrine; DATRY, Annick et al.The Journal of infection. 2012, Vol 64, Num 4, pp 424-429, issn 0163-4453, 6 p.Article

Caspofungin Disk Diffusion Breakpoints and Quality ControlBROWN, Steven D; TRACZEWSKI, Maria M.Journal of clinical microbiology (Print). 2008, Vol 46, Num 6, pp 1927-1929, issn 0095-1137, 3 p.Article

Flow cytometry susceptibility testing for the antifungal caspofunginMITCHELL, M; HUDSPETH, M; WRIGHT, A et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 6, pp 2586-2589, issn 0095-1137, 4 p.Article

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsWALSH, Thomas J; ADAMSON, Peter C; MILLER, Alisha et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4536-4545, issn 0066-4804, 10 p.Article

Les échinocandines : Une nouvelle classe thérapeutique antifongique, un nouveau mécanisme d'action = Echinocandins: a new class of antifungal agents, a new mechanism of actionDATRY, A; THELLIER, M.Journal de mycologie médicale. Supplément. 2002, Vol 12, pp 1S5-1S9, issn 1166-7680Article

Susceptibility to caspofungin of Candida spp. strains isolated in Ceará, Northeastern BrazilROCHA DA SILVA, C; DE SOUSA CAMPOS, R; ADALGIZA DOS SANTOS NETA, M et al.Journal de mycologie médicale. 2011, Vol 21, Num 4, pp 273-276, issn 1156-5233, 4 p.Article

A retrospective nationwide case study on the use of a new antifungal agent : patients treated with caspofungin during 2001-2004 in FinlandANTTILA, V.-J; SALONEN, J; YLIPALOSAARI, P et al.Clinical microbiology and infection. 2007, Vol 13, Num 6, pp 606-612, issn 1198-743X, 7 p.Article

Efficacy and safety of caspofungin for the empiric management of fever in neutropenic childrenKOO, Alicia; SUNG, Lillian; ALIEN, Upton et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 9, pp 854-856, issn 0891-3668, 3 p.Article

In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolatesMAIDA, C. M; MILICI, M. E; OLIVERI, S et al.Journal of chemotherapy. 2007, Vol 19, Num 3, pp 277-282, issn 1120-009X, 6 p.Article

Intérêt de la caspofungine dans le traitement d'une infection disséminée à Fusarium solani ? = Successful use of caspofungin in the treatment of a disseminated Fusarium solani infection?REGUERRE, Y; ALSHGHRI, I; HERBIGNEAUX, R.-M et al.Journal de mycologie médicale (Paris). 2006, Vol 16, Num 1, pp 51-54, issn 1156-5233, 4 p.Article

Nouveaux antifongiques : voriconazole et caspofungine = New antifungal agents: voriconazole and caspofunginDUPONT, B.Archives de pédiatrie (Paris). 2003, Vol 10, pp 592s-598s, issn 0929-693X, SUP5Conference Paper

Successful Treatment of an Infant Infected with Refractory C. parapsilosis with CaspofunginOZKAYA-PARLAKAY, Ashnur; TEZER, Hasan; KAZMACAN, Tugba et al.Journal of tropical pediatrics (1980). 2014, Vol 60, Num 4, pp 329-330, issn 0142-6338, 2 p.Article

Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agentsRIZOS, Evangelos C; SALANTI, Georgia; KONTOYIANNIS, Dimitrios P et al.Journal of clinical epidemiology. 2011, Vol 64, Num 8, pp 830-842, issn 0895-4356, 13 p.Article

Page / 13